belara film-coated tablet 0.03mg2mg
pharmline marketing pte. ltd. - chlormadinone acetate; ethinylestradiol - tablet, film coated - chlormadinone acetate 2.000 mg; ethinylestradiol 0.030 mg
belara 28 2 mg/0,03 mg filmtabletten
cellcept for i.v. infusion 500 mgvial
roche singapore pte. ltd. - mycophenolate mofetil - injection, powder, for solution - 500 mg/vial - mycophenolate mofetil 500 mg/vial
aclasta
sandoz pharmaceuticals d.d. - zoledronic acid - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy in post-menopausal women and in men at increased risk of fracture. treatment of paget's disease of the bone.,
cellcept
roche registration gmbh - mycophenolate mofetil - graft rejection - immunosuppressants - cellcept is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
mycophenolate mofetil teva
teva pharma b.v. - mycophenolate mofetil - graft rejection - immunosuppressants - mycophenolate mofetil teva is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
berotec n pressurised inhalation, solution
boehringer ingelheim pharma gmbh & co. kg - fenoterol (fenoterol hydrobromide) - pressurised inhalation, solution - 100mcg/dose
bilmon - 1 a pharma 0,03 mg/2 mg filmtabletten